ArticleNature communications2025
Catalytic asymmetric synthesis of (N, N)- spiroketal via Pd-catalyzed enantioconvergent aminocarbonylation and dearomative nucleophilic aza-addition.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Catalytic Asymmetric Spiroannulation to Access Polycyclic Spiro Enones via Transient Axial-to-Point Chirality Induction and Transfer.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Chiral spirocyclic skeletons have found widespread applications in asymmetric catalysis, drug discovery, and functional materials due to their rigid three-dimensional architecture and excellent stereochemical stability. However, the structural diversity of accessible spiro frameworks remains limited, constraining their broader utility and functional development. For instance, chiral (N, N)-spiroketals represent a promising class of scaffolds with potential application in asymmetric catalysis and are frequently encountered in natural products and biologically active compounds, yet their efficient synthesis is still underdeveloped. Herein, we present a Pd-catalyzed cascade enantioconvergent aminocarbonylation and intramolecular dearomative nucleophilic aza-addition that enables the efficient synthesis of chiral (N, N)-spiroketal. This formal [3 + 1 + 1] spiroannulation employs racemic quinazoline-derived heterobiaryl triflates, carbon monoxide, and amines to deliver an array of (N, N)-spiroketal in high yields and excellent enantioselectivities. The protocol exhibits wide functional group tolerance, scalability, and downstream synthetic utility, providing access to structurally diverse spirocyclic derivatives. Mechanistic studies reveal that the stereochemical outcome of (N, N)-spiroketal is determined by the atroposelective DyKAT aminocarbonylation step, rather than the subsequent spiroannulation. Moreover, the resulting spiroketal structure has been developed into chiral carbene ligand, as demonstrated by the successful synthesis of its corresponding Rh, Ir, Au and Pd complexes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.